ArticleEuropean journal of haematology2025

Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome.

Man Wai Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.